ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,349 | +211.9% | 34,783 | -20.2% | 0.00% | – |
| Q2 2023 | $14,219 | -24.2% | 43,614 | 0.0% | 0.00% | – |
| Q1 2023 | $18,754 | -25.7% | 43,614 | -8.4% | 0.00% | – |
| Q4 2022 | $25,239 | +1.0% | 47,619 | +36.1% | 0.00% | – |
| Q3 2022 | $25,000 | -39.0% | 34,989 | -3.5% | 0.00% | – |
| Q2 2022 | $41,000 | -45.3% | 36,260 | -1.6% | 0.00% | – |
| Q1 2022 | $75,000 | -73.6% | 36,857 | -62.7% | 0.00% | – |
| Q4 2021 | $284,000 | -37.7% | 98,798 | -8.0% | 0.00% | – |
| Q3 2021 | $456,000 | -69.0% | 107,412 | -61.3% | 0.00% | – |
| Q2 2021 | $1,469,000 | +357.6% | 277,693 | +303.1% | 0.00% | – |
| Q1 2021 | $321,000 | +583.0% | 68,896 | +388.3% | 0.00% | – |
| Q4 2020 | $47,000 | -14.5% | 14,109 | -14.3% | 0.00% | – |
| Q3 2020 | $55,000 | -32.1% | 16,468 | -31.9% | 0.00% | – |
| Q2 2020 | $81,000 | -17.3% | 24,165 | -5.8% | 0.00% | – |
| Q1 2020 | $98,000 | -96.4% | 25,643 | -94.3% | 0.00% | -100.0% |
| Q4 2019 | $2,697,000 | +146.8% | 446,625 | +209.0% | 0.00% | – |
| Q3 2019 | $1,093,000 | -37.4% | 144,525 | +12.2% | 0.00% | – |
| Q2 2019 | $1,745,000 | +214.4% | 128,769 | +25.8% | 0.00% | – |
| Q1 2019 | $555,000 | +1882.1% | 102,379 | +993.2% | 0.00% | – |
| Q4 2018 | $28,000 | -76.9% | 9,365 | -37.2% | 0.00% | – |
| Q3 2018 | $121,000 | -81.4% | 14,904 | -77.7% | 0.00% | – |
| Q2 2018 | $651,000 | +18.1% | 66,789 | +5.4% | 0.00% | – |
| Q1 2018 | $551,000 | -82.4% | 63,345 | -74.7% | 0.00% | -100.0% |
| Q4 2017 | $3,129,000 | +301.2% | 250,040 | +168.4% | 0.00% | – |
| Q3 2017 | $780,000 | +18.2% | 93,161 | +139.2% | 0.00% | – |
| Q2 2017 | $660,000 | -71.6% | 38,942 | -66.3% | 0.00% | – |
| Q1 2017 | $2,322,000 | +313.2% | 115,504 | +220.3% | 0.00% | – |
| Q4 2016 | $562,000 | +141.2% | 36,060 | +101.4% | 0.00% | – |
| Q3 2016 | $233,000 | +232.9% | 17,907 | +76.6% | 0.00% | – |
| Q2 2016 | $70,000 | +112.1% | 10,139 | +189.7% | 0.00% | – |
| Q1 2016 | $33,000 | -2.9% | 3,500 | +4.0% | 0.00% | – |
| Q4 2015 | $34,000 | -76.2% | 3,366 | -66.4% | 0.00% | – |
| Q3 2015 | $143,000 | – | 10,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 4,898,927 | $6,246,132 | 0.70% |
| Yakira Capital Management, Inc. | 620,019 | $790,524 | 0.22% |
| Crystalline Management Inc. | 230,817 | $294,292 | 0.21% |
| DELTEC ASSET MANAGEMENT LLC | 475,000 | $605,625 | 0.14% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,283,979 | $2,912,073 | 0.12% |
| PenderFund Capital Management Ltd. | 123,444 | $213 | 0.06% |
| FIFTH LANE CAPITAL, LP | 100,000 | $127,000 | 0.04% |
| CSS LLC/IL | 476,831 | $607,960 | 0.04% |
| Penserra Capital Management LLC | 220,858 | $280 | 0.01% |
| King Wealth Management Group | 16,000 | $20 | 0.00% |